Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Copaxone’s Tombstone? 2014 Could Be Year Generic Launches, Momenta Says

Executive Summary

FDA “has not to date had any questions that would indicate our application is off track,” CEO Wheeler says as Momenta and partner Sandoz gear up for the launch.

Advertisement

Related Content

Deal Watch: Taking Care Of Business Before J.P. Morgan
Actavis’ Big Bet On A Diversified Hybrid Model
Indian Court Dismisses Teva’s Plea To Halt Natco’s Generic Copaxone Exports
Indian Court Dismisses Teva’s Plea To Halt Natco’s Generic Copaxone Exports
Teva’s More Convenient Copaxone Puts Payors In A Bind
Actavis’ Big Bet On Diversified Hybrid Model Reflects Industry Trends
Copaxone Reduces Its Dosing Schedule, But Can It Shrink The Competition?
Teva’s Final Copaxone Firewall Is Complexity Of ANDA Review After Court Tosses Patent
MS Boon: Many Drugs On The Way, But Will Payors Swallow The Cost?
Managing The World’s First Blockbuster Generic: An Interview With Sandoz’s George

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS055934

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel